stockrow
Saturday 7 November 2026
Export SYRA’s income statement to Excel — free account
Syra Health Corp.
SYRA Healthcare Medical Care Facilities
Syra Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.2 million, down 9.47% from fiscal 2024.
- Revenue
- +51.5%
- EPS
- +221.5%
- Free cash flow
- +235.8%
Quarter to September 2026, against a year earlier
0.80
0.07
−8.05%
Follow SYRA
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Sep ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | 1 | 6 | 6 | 8 | 7 | 9 | +50.5% | — | — | — | — | |
| Gross margin, % | — | — | — | — | — | 30.52 | 18.90 | 25.60 | 20.71 | 34.43 | 42.57 | +3.9 pt | ||||||
| EBT | — | — | — | — | — | 0 | (2) | (3) | (4) | (1) | 1 | +306.0% | ||||||
| EBT margin, % | — | — | — | — | — | (0.23) | (37.71) | (53.28) | (47.10) | (12.40) | 7.33 | (12.2) pt | ||||||
| Net income | — | — | — | — | — | 0 | (2) | (3) | (4) | (1) | 1 | +306.0% | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 1.69 | 1.85 | 1.13 | 1.06 | 0.61 | 0.63 | (22.5%) | |||||
| Earnings | — | — | — | — | — | 0.00 | (0.70) | (0.60) | (0.50) | (0.08) | 0.05 | +112.8% | ||||||
| Cash flow | — | — | — | — | — | (0.11) | (0.74) | (0.57) | (0.39) | (0.04) | 0.05 | (22.7%) | ||||||
| Capex | — | — | — | — | — | (0.01) | (0.04) | 0.00 | 0.00 | 0.00 | 0.00 | n/m | ||||||
| Free cash flow | — | — | — | — | — | (0.11) | (0.78) | (0.57) | (0.39) | (0.04) | 0.05 | (24.0%) | ||||||
| Book value | — | — | — | — | — | (0.01) | 0.23 | 0.82 | 0.38 | 0.18 | 0.21 | n/m | ||||||
| Shares, m | — | — | — | — | — | 1 | 3 | 5 | 8 | 12 | 13 | +94.2% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.73 | 0.0 | |||||
| P/S | — | — | — | — | — | 0.00 | 0.00 | 0.97 | 0.39 | 0.15 | 1.27 | 0.3 | ||||||
| P/B | — | — | — | — | — | 18.50 | 18.50 | 1.34 | 1.08 | 0.51 | 3.76 | 8.0 | ||||||
| EV/Sales | — | — | — | — | — | 0.00 | 0.00 | 0.70 | 0.31 | 0.17 | 1.20 | 0.2 | ||||||
| EV/FCF | — | — | — | — | — | (4.61) | (4.61) | (1.38) | (0.83) | (2.66) | 15.77 | (2.8) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | 0 | (2) | (3) | (3) | 0 | 1 | +50.1% | |||||
| Capex | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | (64.5%) | ||||||
| Free cash flow | — | — | — | — | — | 0 | (2) | (3) | (3) | 0 | 1 | +47.5% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 0 | 0 | 4 | 3 | 2 | 3 | n/m | |||||
| Net debt | — | — | — | — | — | 0 | 1 | (3) | (2) | (2) | (2) | +100.5% | ||||||
| Shareholders’ equity | — | — | — | — | — | 0 | 1 | 4 | 3 | 2 | 3 | n/m | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | (148.31) | (81.14) | (87.40) | (27.78) | 18.73 | (27.8) pt | |||||
| ROIC | — | — | — | — | — | 0.00 | (89.62) | (246.18) | (486.97) | (116.90) | 59.24 | (116.9) pt | ||||||
| ROE | — | — | — | — | — | 0.00 | (602.62) | (124.42) | (109.09) | (36.02) | 26.80 | (36.0) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | 168 | 162 | 94 | 89 | — | (19.1%) | |||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | 0.03 | 0.03 | 0.08 | 0.08 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026
Syra Health Corp. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| BTMD biote Corp. | $37.4M | 6.6× | — (loss-making) | −9.48% (below 0%: shrinking) | n/m | −174.16% (below 0%: shrinking) | 65.38% | (7.93%) | Compare |
| PIII P3 Health Partners Inc. | $28.1M | — (loss-making) | — | +8.60% (above 0%: growing) | n/m | −272.24% (below 0%: shrinking) | 22.26% | 10.67% | Compare |
| DCGO DocGo Inc. | $24.1M | — (loss-making) | — (loss-making) | −8.70% (below 0%: shrinking) | n/m | −132.28% (below 0%: shrinking) | 30.52% | (24.41%) | Compare |
| CCM Concord Medical Services Holdings Limited | $10.0M | — (loss-making) | — (loss-making) | +37.65% (above 0%: growing) | n/m | −281.45% (below 0%: shrinking) | (13.15%) | 0.00% | Compare |
| AMS American Shared Hospital Services | $7.8M | — (loss-making) | 1.8× | +19.22% (above 0%: growing) | n/m | +195.82% (above 0%: growing) | 17.00% | (7.22%) | Compare |
| RHEP Adcare Health Systems Inc | $5.2M | 0.6× | — (loss-making) | +143.03% (above 0%: growing) | n/m | +224.45% (above 0%: growing) | 31.50% | (0.88%) | Compare |
| SYRA Syra Health Corp. | $1.1M | 14.7× | — | +51.50% (above 0%: growing) | n/m | +235.76% (above 0%: growing) | 46.34% | 11.73% | |
| NVOS Novo Integrated Sciences, Inc. | $730.0K | — (loss-making) | — (loss-making) | −6.74% (below 0%: shrinking) | n/m | −111.85% (below 0%: shrinking) | 51.21% | (87.60%) | Compare |
| NIVF NewGenIvf Group Limited | $610.0K | — | — | — | — | — | — | — | Compare |
| Median of peers | $8.9M | — | — | +8.60% | — | −132.28% | 30.52% | (7.22%) |
Pay and ownership Proxy statement filed 1 June 2026
Ownership
Directors and executive officers, together
41.60%
Feroz Syed
14.90%
Priya Prasad
14.80%
Deepika Vuppalanchi
13.20%
Sandeep Allam
12.30%
AOS Holdings, LLC
7.80%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement